Progyny Inc (PGNY)
32.07
-0.21
(-0.65%)
USD |
NASDAQ |
May 02, 14:07
Progyny Revenue (Quarterly): 269.94M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 269.94M |
September 30, 2023 | 280.89M |
June 30, 2023 | 279.37M |
March 31, 2023 | 258.39M |
December 31, 2022 | 214.32M |
September 30, 2022 | 205.37M |
June 30, 2022 | 195.00M |
March 31, 2022 | 172.22M |
December 31, 2021 | 127.55M |
September 30, 2021 | 122.28M |
June 30, 2021 | 128.65M |
Date | Value |
---|---|
March 31, 2021 | 122.13M |
December 31, 2020 | 100.30M |
September 30, 2020 | 98.93M |
June 30, 2020 | 64.60M |
March 31, 2020 | 81.02M |
December 31, 2019 | 65.12M |
September 30, 2019 | 61.20M |
June 30, 2019 | 56.17M |
March 31, 2019 | 47.20M |
December 31, 2018 | 29.19M |
September 30, 2018 | 27.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
56.17M
Minimum
Jun 2019
280.89M
Maximum
Sep 2023
152.81M
Average
127.55M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
Delcath Systems Inc | 0.539M |
Star Equity Holdings Inc | 14.11M |
Exact Sciences Corp | 646.88M |
Illumina Inc | 1.122B |
CytoSorbents Corp | 7.348M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 13.47M |
Total Expenses (Quarterly) | 256.14M |
EPS Diluted (Quarterly) | 0.13 |
Enterprise Value | 2.744B |
Gross Profit Margin (Quarterly) | 21.08% |
Profit Margin (Quarterly) | 4.99% |
Earnings Yield | 1.93% |
Operating Earnings Yield | 1.93% |
Normalized Earnings Yield | 1.933 |